Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Steffen Nielsen, Mateusz K. Sitarz, Priyanshu M. Sinha, Charlemagne A. Folefac, Morten Høyer, Brita S. Sørensen & Michael R. Horsman. (2023) Using immunotherapy to enhance the response of a C3H mammary carcinoma to proton radiation. Acta Oncologica 62:11, pages 1581-1586.
Read now
Read now
Pernille B. Elming, Brita S. Sørensen, Harald Spejlborg, Jens Overgaard & Michael R. Horsman. (2021) Does the combination of hyperthermia with low LET (linear energy transfer) radiation induce anti-tumor effects equivalent to those seen with high LET radiation alone?. International Journal of Hyperthermia 38:1, pages 105-110.
Read now
Read now
Ane B. Iversen, Morten Busk, Lotte B. Bertelsen, Christoffer Laustsen, Ole L. Munk, Thomas Nielsen, Thomas R. Wittenborn, Johan Bussink, Jasper Lok, Hans Stødkilde-Jørgensen & Michael R. Horsman. (2017) The potential of hyperpolarized 13C magnetic resonance spectroscopy to monitor the effect of combretastatin based vascular disrupting agents. Acta Oncologica 56:11, pages 1626-1633.
Read now
Read now
Michael R. Horsman. (2017) Enhancing the radiation response of tumors but not early or late responding normal tissues using a vascular disrupting agent. Acta Oncologica 56:11, pages 1634-1638.
Read now
Read now
Pei-Shin Jiang, Hsin-Yu Tsai, Philip Drake, Fu-Nien Wang & Chi-Shiun Chiang. (2017) Gadolinium-doped iron oxide nanoparticles induced magnetic field hyperthermia combined with radiotherapy increases tumour response by vascular disruption and improved oxygenation. International Journal of Hyperthermia 33:7, pages 770-778.
Read now
Read now
Michael R. Horsman. (2016) Realistic biological approaches for improving thermoradiotherapy. International Journal of Hyperthermia 32:1, pages 14-22.
Read now
Read now
Cai Grau, Jens Overgaard, Morten Høyer, Kari Tanderup, Jacob Christian Lindegaard & Ludvig Paul Muren. (2015) Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality. Acta Oncologica 54:9, pages 1245-1250.
Read now
Read now
Thomas R. Wittenborn & Michael R. Horsman. (2015) Targeting tumour hypoxia to improve outcome of stereotactic radiotherapy. Acta Oncologica 54:9, pages 1385-1392.
Read now
Read now
Michael R. Horsman. (2015) Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation. International Journal of Hyperthermia 31:5, pages 453-459.
Read now
Read now
Daniel J Inglis, Tina C Lavranos, Donna M Beaumont, Annabell F Leske, Chloe K Brown, Allison J Hall & Gabriel Kremmidiotis. (2014) The vascular disrupting agent BNC105 potentiates the efficacy of VEGF and mTOR inhibitors in renal and breast cancer. Cancer Biology & Therapy 15:11, pages 1552-1560.
Read now
Read now
Articles from other publishers (13)
M.R. Horsman, B.S. Sørensen, M. Busk & D.W. Siemann. (2021) Therapeutic Modification of Hypoxia. Clinical Oncology 33:11, pages e492-e509.
Crossref
Crossref
Min-Young Kim, Jung-Young Shin, Jeong-Oh Kim, Kyoung-Hwa Son, Yeon Sil Kim, Chan Kwon Jung & Jin-Hyoung Kang. (2020) Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma. BMC Cancer 20:1.
Crossref
Crossref
Michael R. Horsman, Thomas R. Wittenborn, Patricia S. Nielsen & Pernille B. Elming. (2020) Tumors Resistant to Checkpoint Inhibitors Can Become Sensitive after Treatment with Vascular Disrupting Agents. International Journal of Molecular Sciences 21:13, pages 4778.
Crossref
Crossref
Haiyang Yu, Na Shen, Yanli Bao, Li Chen & Zhaohui Tang. (2020) Tumor regression and potentiation of polymeric vascular disrupting therapy through reprogramming of a hypoxia microenvironment with temsirolimus. Biomaterials Science 8:1, pages 325-332.
Crossref
Crossref
Hanjiao Qin, Haiyang Yu, Jiyao Sheng, Dawei Zhang, Na Shen, Linlin Liu, Zhaohui Tang & Xuesi Chen. (2019)
PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(
l
‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer
. Advanced Science 6:12, pages 1900327.
Crossref
Crossref
Simon Lønbro, Jennifer M. Wiggins, Thomas Wittenborn, Pernille Byrialsen Elming, Lori Rice, Christine Pampo, Jennifer A. Lee, Dietmar W. Siemann & Michael R. Horsman. (2019) Reliability of blood lactate as a measure of exercise intensity in different strains of mice during forced treadmill running. PLOS ONE 14:5, pages e0215584.
Crossref
Crossref
Sven De Bruycker, Christel Vangestel, Steven Staelens, Tim Van den Wyngaert & Sigrid Stroobants. (2018) How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research. Contrast Media & Molecular Imaging 2018, pages 1-17.
Crossref
Crossref
Amir Daei Farshchi Adli, Rana Jahanban-Esfahlan, Khaled Seidi, Sonia Samandari-Rad & Nosratollah Zarghami. (2018) An overview on Vadimezan (DMXAA): The vascular disrupting agent. Chemical Biology & Drug Design 91:5, pages 996-1006.
Crossref
Crossref
Michael R. Horsman & Jens Overgaard. (2016) The impact of hypoxia and its modification of the outcome of radiotherapy. Journal of Radiation Research 57:S1, pages i90-i98.
Crossref
Crossref
Wenjie Liang, Yicheng Ni & Feng Chen. (2016) Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions. Oncotarget 7:13, pages 15444-15459.
Crossref
Crossref
Florence Colliez, Anne‐Catherine Fruytier, Julie Magat, Marie‐Aline Neveu, Patrice D. Cani, Bernard Gallez & Bénédicte F. Jordan. (2015) Monitoring Combretastatin A4–induced tumor hypoxia and hemodynamic changes using endogenous MR contrast and DCE‐MRI. Magnetic Resonance in Medicine 75:2, pages 866-872.
Crossref
Crossref
Dietmar W. Siemann & Michael R. Horsman. (2015) Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacology & Therapeutics 153, pages 107-124.
Crossref
Crossref
Florence Colliez, Marie-Aline Neveu, Julie Magat, Thanh Trang Cao Pham, Bernard Gallez & Bénédicte F. Jordan. (2014) Qualification of a Noninvasive Magnetic Resonance Imaging Biomarker to Assess Tumor Oxygenation. Clinical Cancer Research 20:21, pages 5403-5411.
Crossref
Crossref